Sanofi Pasteur

In a first, WHO recommends quadrivalent influenza vaccine

/ Prasad Ravindranath

Sanofi has launched in India its quadrivalent influenza vaccine (FluQuadri) containing two A virus strains — H1N1 and H3N2 — and two B virus strians — Victoria and Yamagata — for active immunization of adults over 18 years. In February this year, the WHO for the first time recommended the use of quadrivalent influenza vaccine containing two A … Continue reading In a first, WHO recommends quadrivalent influenza vaccine

Advertisement

Single dose of H1N1 vaccine produces robust immune response

/ Prasad Ravindranath

Published in The Hindu on September 12, 2009 The safety of 2009 influenza A(H1N1) vaccines that are undergoing clinical trials in different countries has got a shot in the arm. Fear about the safety of the vaccines, which are being tested on a fast-track mode, was expressed by some doctors in a few countries. Much … Continue reading Single dose of H1N1 vaccine produces robust immune response